Look at the news!Just buy!

2021-12-15

$Galera Therapeutics, Inc.(GRTX)$ Galera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing a proprietary therapeutics that have the potential to transform radiotherapy (RT) in cancer, announced that corrected results from its Phase 3 ROMAN trial of avasopasem for the treatment of RT-induced severe oral mucositis (SOM). Avasopasem has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the reduction of SOM induced by RT.BTIG Upgrades to Buy PT 15.

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":607229988,"tweetId":"607229988","gmtCreate":1639549700766,"gmtModify":1639550587772,"author":{"id":9000000000000375,"authorId":9000000000000375,"authorIdStr":"9000000000000375","name":"TracyArabella","avatar":"https://static.tigerbbs.com/a5aa2773c996a6accd9329dd855f8e45","vip":8,"userType":8,"introduction":"运营账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":10,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"Look at the news!Just buy!","extraTitle":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/GRTX\">$Galera Therapeutics, Inc.(GRTX)$</a> Galera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing a proprietary therapeutics that have the potential to transform radiotherapy (RT) in cancer, announced that corrected results from its Phase 3 ROMAN trial of avasopasem for the treatment of RT-induced severe oral mucositis (SOM). Avasopasem has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the reduction of SOM induced by RT.BTIG Upgrades to Buy PT 15.</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/GRTX\">$Galera Therapeutics, Inc.(GRTX)$</a> Galera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing a proprietary therapeutics that have the potential to transform radiotherapy (RT) in cancer, announced that corrected results from its Phase 3 ROMAN trial of avasopasem for the treatment of RT-induced severe oral mucositis (SOM). Avasopasem has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the reduction of SOM induced by RT.BTIG Upgrades to Buy PT 15.</p></body></html>","text":"$Galera Therapeutics, Inc.(GRTX)$ Galera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing a proprietary therapeutics that have the potential to transform radiotherapy (RT) in cancer, announced that corrected results from its Phase 3 ROMAN trial of avasopasem for the treatment of RT-induced severe oral mucositis (SOM). Avasopasem has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the reduction of SOM induced by RT.BTIG Upgrades to Buy PT 15.","highlighted":1,"essential":1,"paper":2,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/607229988","repostId":0,"isVote":1,"tweetType":1,"viewCount":803,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["GRTX"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":479,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/607229988"}